Mackay Shields LLC Cerus Corp Transaction History

Mackay Shields LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$5.68 - $7.87 $68,160 - $94,440	-12,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $63,000 - $102,720	12,000 New	12,000 $83,000
Q2 2020 Jul 31, 2020	SELL	$4.5 - $7.02 $73,350 - $114,426	-16,300 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$2.87 - $5.49 $46,781 - $89,487	16,300 New	16,300 $75,000

162

143M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $306M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.